Mcl-1 is an anti-apoptotic factor for human hepatocellular carcinoma

  • Authors:
    • Binje Fleischer
    • Henning Schulze-Bergkamen
    • Marcus Schuchmann
    • Achim Weber
    • Stefan Biesterfeld
    • Martina Müller
    • Peter H. Krammer
    • Peter R. Galle
  • View Affiliations

  • Published online on: January 1, 2006     https://doi.org/10.3892/ijo.28.1.25
  • Pages: 25-32
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Defects in apoptosis signaling in hepatocytes contribute to tumorigenesis in hepatocellular carcinoma (HCC). In addition, treatment with chemotherapeutic drugs is often ineffective in HCC patients due to the apoptosis resistance of cancer cells. Anti-apoptotic members of the Bcl-2 family, including myeloid cell leukemia-1 (Mcl-1), which regulate intrinsic apoptosis induction at the mito-chondrial level, are often overexpressed in human cancer, and are implicated with disease grade and prognosis. Yet, little is known about the role of Mcl-1 in HCC. In this study, we analyzed the relevance of Mcl-1 expression for the apop-tosis resistance of human HCC. Mcl-1 protein expression was considerably enhanced in human HCC tissue compared to adjacent non-tumor tissue. In addition, Mcl-1 was prominently expressed in various HCC cell lines. Mcl-1 basal expression is dependent on a functional phosphatidylinositol-3 kinase (PI3K)/Akt signaling pathway; treatment of the cells with a specific PI3 kinase inhibitor led to both decreased Mcl-1 expression and a sensitization towards chemotherapeutic drug-induced apoptosis. Furthermore, the hepatocyte growth factor and epidermal growth factor induced Mcl-1 expression in an Akt- and ERK-dependent manner. Finally, specific upregulation of Mcl-1 in HCC cells inhibited chemotherapeutic drug-induced apoptosis. Our data suggest that Mcl-1 is an important factor for the apoptosis resistance of human HCC, and constitutes an interesting target for HCC therapy.

Related Articles

Journal Cover

January 2006
Volume 28 Issue 1

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Fleischer B, Schulze-Bergkamen H, Schuchmann M, Weber A, Biesterfeld S, Müller M, Krammer PH and Galle PR: Mcl-1 is an anti-apoptotic factor for human hepatocellular carcinoma. Int J Oncol 28: 25-32, 2006.
APA
Fleischer, B., Schulze-Bergkamen, H., Schuchmann, M., Weber, A., Biesterfeld, S., Müller, M. ... Galle, P.R. (2006). Mcl-1 is an anti-apoptotic factor for human hepatocellular carcinoma. International Journal of Oncology, 28, 25-32. https://doi.org/10.3892/ijo.28.1.25
MLA
Fleischer, B., Schulze-Bergkamen, H., Schuchmann, M., Weber, A., Biesterfeld, S., Müller, M., Krammer, P. H., Galle, P. R."Mcl-1 is an anti-apoptotic factor for human hepatocellular carcinoma". International Journal of Oncology 28.1 (2006): 25-32.
Chicago
Fleischer, B., Schulze-Bergkamen, H., Schuchmann, M., Weber, A., Biesterfeld, S., Müller, M., Krammer, P. H., Galle, P. R."Mcl-1 is an anti-apoptotic factor for human hepatocellular carcinoma". International Journal of Oncology 28, no. 1 (2006): 25-32. https://doi.org/10.3892/ijo.28.1.25